カテゴリ： GlobalData, アメリカ, 企業調査

Anthem Inc (ANTM)：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：Anthem Inc (ANTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C9859
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：87
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers managed healthcare related products and administrative services. The company provides various specialty and insurance products and services including radiology benefit management, dental, life and disability insurance benefits, and analytics-driven personal health care. Anthem offers its products and services to large and small employer, federal government, Medicaid and Medicare markets, and individuals. Its various types of medical membership customers include Local Group, Individual, National Accounts, BlueCard, Medicare, Medicaid, and Federal Employee Program (FEP). The company is an independent licensee of the Blue Cross and Blue Shield Association (BCBSA), and has license for insurance operations in all the 50 states of the US. Anthem is headquartered in Indianapolis, Indiana, the US.

Anthem Inc (ANTM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Anthem Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Anthem Inc, Medical Devices Deals, 2012 to YTD 2018 10
Anthem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Anthem Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Linkwell Health Raises US$11 Million In Series C Financing 12
Private Equity 13
LLR Partners, WellPoint And Stanley B. Blaylock Invests In Physicians Immediate Care 13
Partnerships 14
Anthem, HealthCore and Boehringer Ingelheim Enter into Agreement 14
New England Research Institutes Enters into Research Agreement with National Heart Lung and Blood Institute 15
Eli Lilly Enters into Research Agreement with Anthem and HealthCore 16
Debt Offering 17
Anthem Raises USD750 Million in Private Placement of Notes Due 2022 17
Anthem Raises USD850 Million in Private Placement of Notes Due 2024 18
Anthem Raises USD1.6 Billion in Private Placement of Notes Due 2027 19
Anthem Raises USD1.4 Billion in Private Placement of Notes Due 2047 20
Anthem Raises USD900 Million in Private Placement of Notes Due 2020 21
WellPoint Completes Private Placement Of Debentures Due 2042 For US$1.5 Billion 22
WellPoint Completes Public Offering Of Notes Due 2043 For US$1 Billion 24
WellPoint Completes Public Offering Of Notes Due 2015 For US$625 Million 26
WellPoint Completes Public Offering Of Notes Due 2018 For US$625 Million 28
WellPoint Completes Public Offering Of Notes Due 2023 For US$1 Billion 30
WellPoint Completes Public Offering Of Senior Notes Due 2022 For US$850 Million 32
WellPoint Completes Public Offering Of Senior Notes Due 2042 For US$900 Million 33
Acquisition 34
HealthCore Acquires New England Research Institutes (NERI) 34
Anthem Acquires Simply Healthcare 35
WellPoint Completes Acquisition Of Amerigroup For US$4.9 Billion 36
Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 38
Amerigroup Acquires Health Plus From Lutheran Medical Center For US$85 Million 39
Anthem Inc – Key Competitors 41
Anthem Inc – Key Employees 42
Anthem Inc – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 46
Financial Announcements 46
Oct 31, 2018: Anthem reports third quarter 2018 results reflecting strengthening operating performance 46
Jul 25, 2018: Anthem reports second quarter 2018 results reflecting strong overall enterprise-wide execution 48
Apr 25, 2018: Anthem Reports First Quarter 2018 Results Reflecting Strong Medical Cost Performance 50
Jan 31, 2018: Anthem Reports Fourth Quarter and Full Year 2017 Results Reflecting Balanced Performance across Its Business Units 52
Oct 25, 2017: Anthem Reports Third Quarter 2017 Results 55
Jul 26, 2017: Anthem Reports Second Quarter 2017 Results 58
Apr 26, 2017: Anthem Reports First Quarter 2017 Results 60
Feb 01, 2017: Anthem Reports Fourth Quarter and Full Year 2016 Results 63
Corporate Communications 64
May 10, 2018: Chief Operating Officer Deepti Jain to Lead IngenioRx 64
Feb 22, 2018: Anthem Board of Directors Names Elizabeth E. Tallett as Independent Chairman of the Board 65
Jan 31, 2018: Anthem Appoints Bahija Jallal As New Director 66
Dec 07, 2017: Anthem’s Board Welcomes Antonio Neri as New Director 67
Nov 16, 2017: Anthem Names Greg Poulakos President of Anthem Life & Disability Business 68
Nov 06, 2017: Anthem Announces Key Management Changes 69
Aug 30, 2017: Anthem Names Tomas Orozco President of Medicare East Region 70
Aug 24, 2017: Anthem Names Jacquelyn H. Wolf as Executive Vice President, Chief Human Resources Officer 71
Legal and Regulatory 72
Oct 15, 2018: Anthem Pays OCR $16 Million in Record HIPAA Settlement Following Largest U.S. Health Data Breach in History 72
Apr 28, 2017: Anthem Responds to U.S. Court of Appeals Decision on Acquisition of Cigna 73
Feb 09, 2017: Anthem Responds to U.S. District Court’s Decision on Acquisition of Cigna 74
Government and Public Interest 75
Sep 25, 2018: NORD Receives Grant from Anthem Foundation for Expansion of Rare Disease Database 75
Sep 20, 2018: March Of Dimes receives $1.5 million grant from The Anthem Foundation 76
Sep 05, 2018: National Council on Aging awarded grant from the Anthem Foundation to bring aging mastery to thousands of older adults 77
Sep 07, 2017: Anthem: Certain Patients with Type 2 Diabetes Less Likely to Suffer Heart Failure While Taking New Class of Antidiabetic Drug 78
Aug 23, 2017: Anthem Reaches Goal Two Years Early for Health Plans to Reduce Opioids Filled at Pharmacy by 30 Percent 79
Product News 80
Nov 08, 2017: Anthem Health Plans Play Major Role in Trial to Determine Best Aspirin Dose to Prevent Heart Attacks and Strokes 80
Other Significant Developments 81
Oct 11, 2018: Anthem activates plan to help residents impacted by Hurricane Michael 81
Sep 13, 2018: Anthem activates plan to help residents in states impacted by hurricane florence 82
Jun 12, 2018: Anthem Blue Cross and Blue Shield Adds Decatur County Memorial Hospital to Its Medicare Advantage Provider Network 83
May 22, 2018: Anthem Announces Plans to Remain Headquartered in Indianapolis 84
Oct 18, 2017: Anthem Launches IngenioRx, New Pharmacy Benefits Manager 85
Sep 21, 2017: UniCare Health Plan in West Virginia Takes Action to Help Treat Substance Use Disorder Across the State 86
Appendix 87
Methodology 87
About GlobalData 87
Contact Us 87
Disclaimer 87

List of Tables
Anthem Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Anthem Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Anthem Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Anthem Inc, Medical Devices Deals, 2012 to YTD 2018 10
Anthem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Linkwell Health Raises US$11 Million In Series C Financing 12
LLR Partners, WellPoint And Stanley B. Blaylock Invests In Physicians Immediate Care 13
Anthem, HealthCore and Boehringer Ingelheim Enter into Agreement 14
New England Research Institutes Enters into Research Agreement with National Heart Lung and Blood Institute 15
Eli Lilly Enters into Research Agreement with Anthem and HealthCore 16
Anthem Raises USD750 Million in Private Placement of Notes Due 2022 17
Anthem Raises USD850 Million in Private Placement of Notes Due 2024 18
Anthem Raises USD1.6 Billion in Private Placement of Notes Due 2027 19
Anthem Raises USD1.4 Billion in Private Placement of Notes Due 2047 20
Anthem Raises USD900 Million in Private Placement of Notes Due 2020 21
WellPoint Completes Private Placement Of Debentures Due 2042 For US$1.5 Billion 22
WellPoint Completes Public Offering Of Notes Due 2043 For US$1 Billion 24
WellPoint Completes Public Offering Of Notes Due 2015 For US$625 Million 26
WellPoint Completes Public Offering Of Notes Due 2018 For US$625 Million 28
WellPoint Completes Public Offering Of Notes Due 2023 For US$1 Billion 30
WellPoint Completes Public Offering Of Senior Notes Due 2022 For US$850 Million 32
WellPoint Completes Public Offering Of Senior Notes Due 2042 For US$900 Million 33
HealthCore Acquires New England Research Institutes (NERI) 34
Anthem Acquires Simply Healthcare 35
WellPoint Completes Acquisition Of Amerigroup For US$4.9 Billion 36
Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 38
Amerigroup Acquires Health Plus From Lutheran Medical Center For US$85 Million 39
Anthem Inc, Key Competitors 41
Anthem Inc, Key Employees 42
Anthem Inc, Subsidiaries 43

List of Figures
Anthem Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Anthem Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Anthem Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Anthem Inc (ANTM)：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Gulfsands Petroleum plc (GPX)：企業の財務・戦略的SWOT分析
    Summary Gulfsands Petroleum plc (Gulfsands) is an oil and gas company that offers exploration, development, and production services. The company carries out acquisition, exploration, develops, and produces oil and natural gas. It holds interests in oil exploration and development projects in the Syr …
  • Constantia Industries AG：企業の戦略的SWOT分析
    Constantia Industries AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Hibbett Sports Inc：企業の戦略・SWOT・財務分析
    Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report Summary Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CeoTronics AG (CEK)：企業の財務・戦略的SWOT分析
    CeoTronics AG (CEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Vermont Electric Cooperative Inc：企業の戦略的SWOT分析
    Vermont Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Sinopec Shanghai Petrochemical Company Limited：企業の戦略・SWOT・財務分析
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • De La Rue Plc
    De La Rue Plc - Strategy, SWOT and Corporate Finance Report Summary De La Rue Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Geberit AG：戦略・SWOT・企業財務分析
    Geberit AG - Strategy, SWOT and Corporate Finance Report Summary Geberit AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Ternium SA：企業の戦略・SWOT・財務情報
    Ternium SA - Strategy, SWOT and Corporate Finance Report Summary Ternium SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Syntel, Inc.：戦略・SWOT・企業財務分析
    Syntel, Inc. - Strategy, SWOT and Corporate Finance Report Summary Syntel, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ReVision Optics Inc：医療機器：M&Aディール及び事業提携情報
    Summary ReVision Optics Inc (ROI), formerly IntraLens Vision Inc is a medical device company offers optical solutions. The company offers Raindrop near vision inlay that offers a long term solution to near vision loss caused by aging. It develops products made of water materials that are implanted i …
  • Sc Arcada Con Srl：企業の戦略的SWOT分析
    Sc Arcada Con Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Eisai Co., Ltd.：企業のM&A・事業提携・投資動向
    Eisai Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eisai Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Pivot Pharmaceuticals Inc (PVOTF)：製薬・医療：M&Aディール及び事業提携情報
    Summary Pivot Pharmaceuticals Inc (Pivot Pharmaceuticals), formerly Neurokine Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development and commercialization of cannabinoid based neutraceutical and pharmaceutical products. The company’s major product offerings include capsul …
  • Fluidigm Corp (FLDM)：医療機器：M&Aディール及び事業提携情報
    Summary Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instrumen …
  • CorEnergy Infrastructure Trust Inc (CORR)：石油・ガス：M&Aディール及び事業提携情報
    Summary CorEnergy Infrastructure Trust Inc (CorEnergy) is an energy infrastructure real estate investment trust. The company owns assets in the midstream and downstream US energy sectors that perform functions, such as pipelines, storage terminals, and transmission and distribution assets. Its portf …
  • Strabag SE：企業のM&A・事業提携・投資動向
    Strabag SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Strabag SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Memry Corp：企業の戦略的SWOT分析
    Memry Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Canadian Zeolite Corp.：企業の戦略・SWOT・財務情報
    Canadian Zeolite Corp. - Strategy, SWOT and Corporate Finance Report Summary Canadian Zeolite Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Vivus Inc (VVUS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Vivus Inc (Vivus) is a biopharmaceutical company which develops and commercializes next-generation therapeutics for addressing unmet needs in obesity, sleep apnea, diabetes and sexual health. The company's marketed products include, Qsymia (phentermine and topiramate extended-release), indic …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆